Andrew J. Saurin

Andrew J. Saurin

Auto-generated profile, based on publicly available information

Andrew J. Saurin

Aix Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Parc Scientifique de Luminy, Aix Marseille Univ, 13009, Marseille, France

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2001 in Nature
Verified
Journal Article
Closed access
PDF file
ASAndrew J. Saurin
Andrew J. Saurin
ZSZhaohui Shao
Zhaohui Shao
HEHediye Erdjument-Bromage
Hediye Erdjument-Bromage
Paul TempstPaul Tempst
Paul Tempst
RKRobert E. Kingston
Robert E. Kingston

1 September 2001 in Molecular Cell
Verified
Journal Article
Closed access
NFNicole J Francis
Nicole J Francis
ASAndrew J Saurin
Andrew J Saurin
ZSZhaohui Shao
Zhaohui Shao
RKRobert E Kingston
Robert E Kingston

24 August 1998 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ASAndrew J. Saurin
Andrew J. Saurin
CSCarol Shiels
Carol Shiels
JWJill Williamson
Jill Williamson
DSDavid P.E. Satijn
David P.E. Satijn
AOArie P. Otte
Arie P. Otte
PFPaul S. Freemont
Paul S. Freemont
The Polycomb group (PcG) complex is a chromatin-associated multiprotein complex, involved in the stable repression of homeotic gene activity in Drosophila. Recently, a mammalian PcG complex has been identified with several PcG proteins implicated in the regulation of Hox gene expression. Although the mammalian PcG complex appears analogous to the complex in Drosophila, the molecular mechanisms and functions for the mammalian PcG complex remain unknown. Here we describe a detailed characterization of the human PcG complex in terms of cellular localization and chromosomal association. By using antibodies that specifically recognize three human PcG proteins— RING1, BMI1, and hPc2—we demonstrate in a number of human cell lines that the PcG complex forms a unique discrete nuclear structure that we term PcG bodies. PcG bodies are prominent novel nuclear structures with the larger PcG foci generally localized near the centromeres, as visualized with a kinetochore antibody marker. In both normal fetal and adult fibroblasts, PcG bodies are not randomly dispersed, but appear clustered into defined areas within the nucleus. We show in three different human cell lines that the PcG complex can tightly associate with large pericentromeric heterochromatin regions (1q12) on chromosome 1, and with related pericentromeric sequences on different chromosomes, providing evidence for a mammalian PcG–heterochromatin association. Furthermore, these heterochromatin-bound PcG complexes remain stably associated throughout mitosis, thereby allowing the potential inheritance of the PcG complex through successive cell divisions. We discuss these results in terms of the known function of the PcG complex as a transcriptional repression complex.

1 March 2001 in Genes & Development
Verified
Journal Article
Open access
PDF file
SSSaid Sif
Said Sif
ASAndrew J. Saurin
Andrew J. Saurin
AIAnthony N. Imbalzano
Anthony N. Imbalzano
RKRobert E. Kingston
Robert E. Kingston
Alteration of nucleosomes by ATP-dependent remodeling complexes represents a critical step in the regulation of transcription. The human SWI/SNF (hSWI/SNF) family is composed of complexes that contain either Brg1 or hBrm as the central ATPase; however, these separate complexes have not been compared functionally. Here we describe the establishment of cell lines that express epitope-tagged Brg1 and hBrm and a characterization of the complexes associated with these two ATPases. We show that Brg1 fractionates into two complexes that differ in activity and subunit composition, whereas hBrm is found in one complex with lower activity than the Brg1 complexes. These three complexes can remodel nucleosomal arrays, increase restriction enzyme accessibility, and hydrolyze ATP in a DNA-dependent manner. The three complexes differ markedly in their ability to remodel mononucleosomal core particles. We also show that the hBrm complex and one of the Brg1 complexes contain components of the mammalian Sin3 (mSin3) complex. In addition, we have found that Brg1, hBrm, and BAF155 can interact specifically with mSin3A in vitro, showing a direct association of hSWI/SNF complexes with proteins involved in gene repression. These unexpected functional characteristics indicate that these hSWI/SNF complexes play diverse regulatory roles.

1 November 2002 in Cell
Verified
Journal Article
Closed access
WRWolfgang Rottbauer
Wolfgang Rottbauer
ASAndrew J. Saurin
Andrew J. Saurin
HLHeiko Lickert
Heiko Lickert
XSXuetong Shen
Xuetong Shen
CBC.Geoff Burns
C.Geoff Burns
MFMark Fishman
Mark Fishman

8 August 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
María ArechederraMaría Arechederra
María Arechederra
FDFabrice Daian
Fabrice Daian
AYAnnie Yim
Annie Yim
SBSehrish K. Bazai
Sehrish K. Bazai
SRSylvie Richelme
Sylvie Richelme
Flavio MainaFlavio Maina
Flavio Maina
Epigenetic modifications such as aberrant DNA methylation reshape the gene expression repertoire in cancer. Here, we used a clinically relevant hepatocellular carcinoma (HCC) mouse model (Alb-R26Met) to explore the impact of DNA methylation on transcriptional switches associated with tumorigenesis. We identified a striking enrichment in genes simultaneously hypermethylated in CpG islands (CGIs) and overexpressed. These hypermethylated CGIs are located either in the 5′-UTR or in the gene body region. Remarkably, such CGI hypermethylation accompanied by gene upregulation also occurs in 56% of HCC patients, which belong to the “HCC proliferative-progenitor” subclass. Most of the genes upregulated and with hypermethylated CGIs in the Alb-R26Met HCC model undergo the same change in a large proportion of HCC patients. Among reprogrammed genes, several are well-known oncogenes. For others not previously linked to cancer, we demonstrate here their action together as an “oncogene module”. Thus, hypermethylation of gene body CGIs is predictive of elevated oncogene levels in cancer, offering a novel stratification strategy and perspectives to normalise cancer gene dosages.